4XS.F : Summary for EXPRESS SCRIPTS HLDG - Yahoo Finance

U.S. Markets close in 2 hrs 4 mins

Express Scripts Holding Company (4XS.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
66.77-0.68 (-1.01%)
As of 3:51PM CET. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close67.45
Bid67.94 x 50000
Ask68.10 x 50000
Day's Range66.77 - 66.99
52 Week Range58.50 - 73.62
Avg. Volume104
Market Cap41.17B
PE Ratio (TTM)15.78
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Bloomberg12 days ago

    Cheating Death Can Cost $200,000 as Cancer Leads Sales

    Years before becoming a top cancer specialist, Eric Winer used to save money on his own medical care by talking U.S. pharmacists into giving him expired treatments for free.

  • American City Business Journals29 days ago

    Year In Review 2016: Leadership changes at Express Scripts, Centene expansion headline health care

    A new leader took the reins at St. Louis’ largest public company in 2016. Tim Wentworth officially added the title of CEO to his role as president of Express Scripts, the pharmacy benefits manager that had 2015 revenue of $101.8 billion, in May. He succeeded George Paz, who announced in 2015 that he would be stepping down.Paz, who became Express Scripts’ CEO in 2005, continues to serve as chairman of the company. Another local public company in the health care industry also had big news in 2016: Centene closed in March on its $6 billion acquisition of California-based Health Net Inc .

  • Market Realist29 days ago

    Factors behind Horizon Pharma’s Volatility in December

    With the Express Scripts agreement, Horizon Pharma’s net sales in 2017 are expected to rise. The probability of a top-line expansion has boosted investor sentiment.